ArticleJCO precision oncology2024

False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring

Jaleh Fallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.